Myofibroblastic tumors are rare lesions which can affect any part of the body. Although benign, their mass effect causes symptoms that can become life-threatening. Supraglottic laryngeal involvement is extremely rare, with only 4 cases described in the English literature. Because the pathophysiology is unknown and the incidence is so low, there is no standardized therapeutic management, although for laryngeal tumors surgery has traditionally been the preferred initial option. Another less common option is intravenous and oral corticosteroid therapy, but this is usually reserved for myofibroblastic tumors in other head and neck sites that are more difficult to access surgically, or patients who cannot undergo surgery. These lesions have a very high tendency to recur, and morbidity rates are therefore also high. We present a case of supraglottic myofibroblastic tumor in which we elected high-dose corticosteroid therapy as the only form of treatment. With this new therapeutic approach, we avoided the undesirable effects of the usual type of surgery. At the 12-month follow-up, the patient is in complete remission.
Objective: To know the impact of the disease in a second level care hospital, which are the signs and symptoms shown by infected patients, which are the treatments usually administrated and which services are admitted.
Material and methods: Retrospective descriptive analytical study among the population attending the Emergency service of Rafael Méndez Hospital of Lorca between January 1st 2011 and December 31st 2019 with an infectious mononucleosis diagnosis. Once the sample was obtained, the necessary clinical and analytical variables were collected from the clinical records.
Results: 600 patients attended to the emergency service with a clinical diagnosis of infectious mononucleosis, which supposes an incidence of 0.4 cases each 1000 habitants per year. 42 patients with a middle age from 16.8 ± 9.26 years old were included, being 57.1% women. The serology for Epstein-Bar was positive on 29 patients, positive for cytomegalovirus on 1 patient and negative for both on 12 patients. The most frequent symptoms presented were fever (66.7%), odynophagia (73.3%) and dysphagia (62.7%). The alteration of the hepatic enzymes was observed on an 81.6%. Admission were made by internal medicine (44.4%), otorhinolaryngology (33.3%) and paediatrics (16.7%). The 55.5% (25) of patients was following a treatment with antibiotics at the moment of the admission.
Conclusion: Mononucleosis usually presents mild symptoms and low rates of hospital admission. Asthenia has showed, in a significant way, a symptom linked to EBV mononucleosis. Neutropenia, thrombocytopenia, and elevated transaminases are the most distinctive laboratory features in EBV infectious mononucleosis. Training of primary care physicians would be useful in order to avoid the use of unnecessary antibiotics
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.